Promoting Early Identification of Systemic Anti-Cancer Therapies Side Effects: Two Approaches

In response to concerns that patients often delay reporting serious Systemic Anti-Cancer Therapy (SACT) side effects, the National Chemotherapy Board (NCB) has developed guidance to improve side effect reporting. Two complementary approaches are suggested: Firstly empowerment, which focuses on equipping patients to take responsibility for identifying and reporting important side effects. This may be mediated through technology such as use of mobile phones or the internet.
 
Secondly, proactive monitoring, which includes clinician interventions (e.g. telephone support or home visits). There is some evidence that patients find pro-active calls from nurses supportive and reassuring during SACT. Current evidence suggests that proactive monitoring results in earlier symptom management than patient self reports.
 
To read the guidance, please click here.